Recall Register

Device recall: Dimension Thyroid Stimulating Hormone (TSHL) Flex reagent cartridge

Class II FDA enforcement event 79505. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these…

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Siemens Healthcare Diagnostics, Inc. started this device recall on 2 Jan 2018. The firm address in the FDA record is in Tarrytown, NY. FDA put the recall in Class II. FDA event 79505 has 24 product records. The first FDA enforcement report date is 16 May 2018. The record gives the status Terminated, with the termination date 10 Feb 2023.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide and Canada, Mexico, and Thailand

Recalling firm

Siemens Healthcare Diagnostics, Inc., Tarrytown, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

24 product records in the event.

FDA event 79505: product records
Recall numberProductQuantityClassStatusReport date
Z-1668-2018Dimension Thyroid Stimulating Hormone (TSHL) Flex reagent cartridgeN/AClass IITerminated16 May 2018
Z-1669-2018Dimension Free Thyroxine (FT4L) Flex reagent cartridgeN/AClass IITerminated16 May 2018
Z-1670-2018Dimension Sirolimus (SIRO) Flex reagent cartridgeN/AClass IITerminated16 May 2018
Z-1671-2018Dimension Vista Cardiac Troponin I (CTNI) Flex reagent cartridgeN/AClass IITerminated16 May 2018
Z-1672-2018Dimension Vista Mass Creatine Kinase (MMB) Flex reagent cartridgeN/AClass IITerminated16 May 2018
Z-1673-2018Dimension Vista Thyroid Stimulating Hormone (TSH) Flex reagent cartridgeN/AClass IITerminated16 May 2018
Z-1674-2018IMMULITE 2000/IMMULITE 2000 XPi 3g Allergy specific IgE Universal KitN/AClass IITerminated16 May 2018
Z-1675-2018IMMULITE 2000/IMMULITE 2000 XPi Anti HBcN/AClass IITerminated16 May 2018
Z-1676-2018IMMULITE 2000/IMMULITE 2000 XPi Folic AcidN/AClass IITerminated16 May 2018
Z-1677-2018IMMULITE /IMMULITE 1000 BR-MA (CA15-3)N/AClass IITerminated16 May 2018
Z-1678-2018IMMULITE /IMMULITE 1000 CEAN/AClass IITerminated16 May 2018
Z-1679-2018IMMULITE 2000/IMMULITE 2000 XPi CEAN/AClass IITerminated16 May 2018
Z-1680-2018IMMULITE /IMMULITE 1000 GastrinN/AClass IITerminated16 May 2018
Z-1681-2018IMMULITE 2000/IMMULITE 2000 XPi GastrinN/AClass IITerminated16 May 2018
Z-1682-2018IMMULITE /IMMULITE 1000 OM-MA (CA125)N/AClass IITerminated16 May 2018
Z-1683-2018IMMULITE 2000/IMMULITE 2000 XPi OM-MA (CA125)N/AClass IITerminated16 May 2018
Z-1684-2018IMMULITE /IMMULITE 1000 TGN/AClass IITerminated16 May 2018
Z-1685-2018IMMULITE 2000/IMMULITE 2000 XPi TGN/AClass IITerminated16 May 2018
Z-1686-2018IMMULITE /IMMULITE 1000 Vitamin B12N/AClass IITerminated16 May 2018
Z-1687-2018ADVIA Centaur CyclosporineN/AClass IITerminated16 May 2018
Z-1688-2018ADVIA Centaur DHEA-SO4N/AClass IITerminated16 May 2018
Z-1689-2018ADVIA Centaur Folate (FOL)N/AClass IITerminated16 May 2018
Z-1690-2018ADVIA Centaur HBc IgM6Class IITerminated16 May 2018
Z-1691-2018IMMULITE 2000/IMMULITE 2000 XPi BR-MA (CA15-3)N/AClass IITerminated16 May 2018

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2018
1,074
Share of these events in Class II
92%
Product records in this event
24Median of the firm: 1
Events of the firm on the register
333

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 79505. https://recallregister.com/fda/ii/79505/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide and Canada, Mexico, and Thailand
What quantity of product is in FDA event 79505?
The event has 24 product records. The first record gives this quantity: N/A
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2018 have the same class?
92% of the 1,074 device events that started in 2018 are in Class II.